Cepheid
Cepheid is a molecular diagnostics company that develops, manufactures, and markets automated, cartridge-based nucleic acid amplification systems and consumables for rapid pathogen and genetic marker detection. Its integrated sample-to-answer platforms (for example, the GeneXpert family) enable decentralized and central-laboratory testing with fast turnaround times for infectious diseases, antimicrobial resistance, and other clinical applications, simplifying complex PCR workflows and supporting clinical decision-making.
Leadership & Board
- Current Number of Employees
- 4,641
- Current LinkedIn Followers
- 187,108
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $64M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $64M
- Latest Funding Round
- Investment
- Post-Money Valuation
- ―
Company Momentum Positive
Cepheid LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Employee Trend
Cepheid had 4,641 employees as of October 12, 2026. The number of employees decreased by 6 (0.13%) week-over-week.
Social Trend
Cepheid had 187,108 followers as of October 12, 2026. The number of followers increased by 371 (0.20%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 22, 2021 | Investment | $63.80M | ― |
Similar Companies
A snapshot of private companies similar to Cepheid, helping you discover and navigate related company profiles.
Related News and Analysis
